1 Lu H, Simonetta F, Samii K, Juillet C. Makrophagenaktivierungssyndrom. Swiss Medical Forum. 2017; 17 (28–29): 604–10.
2 Ramos-Casals M, Lopez-Guillermo A, Khamashta M, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014; 383: 1503–16.
3 Fardet L, Galivier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–20
4 Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.
5 Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, et al. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am J Clin Pathol. 2016;145(6):862–70.
6 Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577.
Empfohlene Zusatzliteratur
– Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125:2908–14.
– Jordan MB, Allen CE. How I treat hemopaghocytic lymphohistiocytosis. Blood. 2011;118:4041–52.